STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Operating expenses:
Research and development	$ 22,388	$ 14,723	$ 60,691	$ 45,385
General and administrative	6,294	5,971	18,661	19,263
Acquired in-process research and development	0	5,000	0	5,000
Total operating expenses	28,682	25,694	79,352	69,648
Loss from operations	(28,682)	(25,694)	(79,352)	(69,648)
Other income, net	3,204	865	6,985	1,373
Net loss	(25,478)	(24,829)	(72,367)	(68,275)
Other comprehensive income (loss):
Unrealized gain (loss) on investments	198	(516)	922	(1,644)
Comprehensive loss	$ (25,280)	$ (25,345)	$ (71,445)	$ (69,919)
Net loss per share, basic	$ (0.44)	$ (0.63)	$ (1.46)	$ (1.73)
Net loss per share, diluted	$ (0.44)	$ (0.63)	$ (1.46)	$ (1.73)
Weighted-average shares outstanding, basic	57,402,226	39,575,660	49,424,418	39,496,864
Weighted-average shares outstanding, diluted	57,402,226	39,575,660	49,424,418	39,496,864